Filed: 8/14/2025ACC: 0001420506-25-002005
📋 What this filing means
B GROUP, INC. filed this quarterly 13F‑HR report disclosing 17 equity positions with a total reported market value of $129.94M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
17
Positions
$129.94M
Total AUM (reported)
11.77M
Total Shares
Allocation by class
COM$70.97M54.6%
COM PAR $.01$15.60M12.0%
ADR$13.99M10.8%
PUT$11.69M9.0%
COM NEW$6.10M4.7%
SPON ADS$4.97M3.8%
COM SHS$4.16M3.2%
Portfolio Concentration
Top 3$71.79M55.3%
4–10$44.65M34.4%
11–25$13.50M10.4%
Top 3 weight
55.3%
Top 10 weight
89.6%
Voting Authority Distribution
Total shares with voting rights: 11.77M
Sole
Full voting authority
11.77M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole17
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings17
Rows:
ADMA BIOLOGICS INC
SOLEShares2.32M
TypeSH
Market value$42.20M
32.48%
Sole
2.32M
Shared
0.00
None
0.00
INSMED INC
SOLEShares155K
TypeSH
Market value$15.60M
12.01%
Sole
155K
Shared
0.00
None
0.00
ZAI LAB LTD
SOLEShares400K
TypeSH
Market value$13.99M
10.77%
Sole
400K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares232.45K
TypeSH
Market value$12.40M
9.55%
Sole
232.45K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares15K
TypeSH
Market value$11.69M
9.00%
Sole
15K
Shared
0.00
None
0.00
CELLECTIS S A
SOLEShares3.26M
TypeSH
Market value$4.97M
3.82%
Sole
3.26M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares1.80M
TypeSH
Market value$4.16M
3.20%
Sole
1.80M
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares110K
TypeSH
Market value$4.00M
3.08%
Sole
110K
Shared
0.00
None
0.00
SIGHT SCIENCES INC
SOLEShares930K
TypeSH
Market value$3.84M
2.96%
Sole
930K
Shared
0.00
None
0.00
AURA BIOSCIENCES INC
SOLEShares572.58K
TypeSH
Market value$3.58M
2.76%
Sole
572.58K
Shared
0.00
None
0.00
ASSEMBLY BIOSCIENCES INC
SOLEShares189.35K
TypeSH
Market value$3.43M
2.64%
Sole
189.35K
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares1.50M
TypeSH
Market value$2.58M
1.99%
Sole
1.50M
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares67.60K
TypeSH
Market value$2.46M
1.89%
Sole
67.60K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares35K
TypeSH
Market value$1.52M
1.17%
Sole
35K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares35K
TypeSH
Market value$1.47M
1.13%
Sole
35K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares80K
TypeSH
Market value$1.20M
0.92%
Sole
80K
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares75K
TypeSH
Market value$840.8K
0.65%
Sole
75K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ADMA BIOLOGICS INCSOLE | COM | 2.32M | SH | $42.20M 32.48% | 2.32M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 155K | SH | $15.60M 12.01% | 155K | 0.00 | 0.00 |
ZAI LAB LTDSOLE | ADR | 400K | SH | $13.99M 10.77% | 400K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 232.45K | SH | $12.40M 9.55% | 232.45K | 0.00 | 0.00 |
ELI LILLY & COSOLE | PUT | 15K | SH | $11.69M 9.00% | 15K | 0.00 | 0.00 |
CELLECTIS S ASOLE | SPON ADS | 3.26M | SH | $4.97M 3.82% | 3.26M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 1.80M | SH | $4.16M 3.20% | 1.80M | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 110K | SH | $4.00M 3.08% | 110K | 0.00 | 0.00 |
SIGHT SCIENCES INCSOLE | COM | 930K | SH | $3.84M 2.96% | 930K | 0.00 | 0.00 |
AURA BIOSCIENCES INCSOLE | COM | 572.58K | SH | $3.58M 2.76% | 572.58K | 0.00 | 0.00 |
ASSEMBLY BIOSCIENCES INCSOLE | COM NEW | 189.35K | SH | $3.43M 2.64% | 189.35K | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | COM | 1.50M | SH | $2.58M 1.99% | 1.50M | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | CALL | 67.60K | SH | $2.46M 1.89% | 67.60K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 35K | SH | $1.52M 1.17% | 35K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 35K | SH | $1.47M 1.13% | 35K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 80K | SH | $1.20M 0.92% | 80K | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 75K | SH | $840.8K 0.65% | 75K | 0.00 | 0.00 |